David M. Lyerly

University Of Virginia Charlottesville

$2,329,818

Attributed

$2,329,818

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $481K · FY2005–12

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$2,329,818 · 4

By mechanism

R43$1,197,605 · 2

R41$979,495 · 1

P01$152,718 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia Charlottesville

Same institution · by research overlap

Barbara J Mann$2,728,160
Tracy D. Wilkins$152,718
Molly A Hughes$6,444,579
Thomas J Braciale$22,435,148
Sheila E. Crowe$6,982,575

Others in their field

Top investigators on “Entamoeba Histolytica”

William A Petri · University Of Virginia$21,488,540
Upinder Singh · Stanford University$13,924,073
Sharon L Reed · University Of California San Diego$12,420,855
Christopher Fox · Access To Advanced Health Institute$8,540,962
Lars Eckmann · University Of California San Diego$8,004,561
Joel F Herbein · Techlab, Inc.$6,789,761

Research focus

Entamoeba HistolyticaAmebiasisVaccine DevelopmentLiver AbscessLectinProtozoal AntigenEscherichia ColiBiotechnologyEnzyme Linked Immunosorbent AssayDiarrheaDiagnosis Design /EvaluationPeptide Chemical SynthesisMolecular CloningProtozoal VaccineCommunicable Disease DiagnosisDiagnostic TestsRecombinant ProteinsBiomedical ResearchAnimal ModelBiodefenseChildAmebic ColitisAgreementAdherence (Attribute)